biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by wesdevrieson Feb 13, 2013 2:19pm

117 Views

Post# 20983029

RE: RE: RE: RE: RE: RE: RE: RE: It's a 'western' t

The broader point here is that it's a discussion. A cordial discussion. An attempt to gain information and clarity. You will note that pmrider's post is a counter argument, professional with no hint of rudeness or hostility or ego about being "right"!

I agree Kayaker, it's a great discussion!

Retraction........one thing I hate is stupidity, and Dr J is the complete definition of that. I have absolutely no use for this person!

wdv

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario